2023
DOI: 10.1016/j.pscia.2022.100001
|View full text |Cite
|
Sign up to set email alerts
|

Covalent coating strategy for enhancing the biocompatibility and hemocompatibility of blood-contacting medical materials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 75 publications
0
8
0
Order By: Relevance
“…To assess the in vitro hemocompatibility of NMIC derivatives, tests were chosen with the help of which it is possible to assess the effect on the coagulation of whole blood and platelet-poor human plasma (BRT, APTT), as well as on the aggregation of human platelets and, indirectly (according to the degree of hemolysis), on the cell membrane of human erythrocytes [ 41 ]. Incubation in a blood/plasma test tube of compounds with anticoagulant activity (coagulation factor inhibitors or plasma coagulation factor inhibitors activators) leads to an increase in coagulation time in coagulological tests [ 21 ]. To activate clotting, a calcium chloride solution was used in the BRT test, since during blood stabilization, calcium ions necessary for coagulation bind to sodium citrate [ 35 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…To assess the in vitro hemocompatibility of NMIC derivatives, tests were chosen with the help of which it is possible to assess the effect on the coagulation of whole blood and platelet-poor human plasma (BRT, APTT), as well as on the aggregation of human platelets and, indirectly (according to the degree of hemolysis), on the cell membrane of human erythrocytes [ 41 ]. Incubation in a blood/plasma test tube of compounds with anticoagulant activity (coagulation factor inhibitors or plasma coagulation factor inhibitors activators) leads to an increase in coagulation time in coagulological tests [ 21 ]. To activate clotting, a calcium chloride solution was used in the BRT test, since during blood stabilization, calcium ions necessary for coagulation bind to sodium citrate [ 35 ].…”
Section: Resultsmentioning
confidence: 99%
“…To activate clotting, a calcium chloride solution was used in the BRT test, since during blood stabilization, calcium ions necessary for coagulation bind to sodium citrate [ 35 ]. The method was developed many years ago to control the level of unfractionated heparin (an activator of plasma inhibitors of coagulation factors) during artificial blood circulation [ 21 ]. At concentrations of 0.083 µg/mL and 0.830 µg/mL, all NMIC derivatives and NMIC2, NMIC3, NMIC4 and NMIC5 at concentrations of 8.300 µg/mL did not affect blood coagulation in the BRT test ( Figure 4 ).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The design and implementation of functional coatings is nowadays a topic of active research in a variety of healthrelated applications such as tissue engineering, bioelectronic devices, prevention of microbial proliferation, control of oxidative stress and inflammation, as well as medical diagnostics and therapy (theranostics) [1][2][3][4] and particularly in nanomedicine, in which the functionalization of nanostructures is of crucial importance to biocompatibility, blood circulation time and the ability to cross biological barriers. [5][6][7][8] Other fields of application include food packaging, material surfaces and interfaces modifications e. g., corrosion inhibition, metal removal through functionalized membranes till catalysis and energy applications. [9][10][11][12] For many applications, particularly in the biomedical sector, wet adhesion is an important requisite.…”
Section: Introduction: Functional Coatingsmentioning
confidence: 99%
“…These materials encompass both synthetic biostable polymers, such as polyethylene and polyurethane (PU), as well as various biodegradable polymers like polycaprolactone (PCL) and polylactic acid, only to cite a few of them. [3,5,6] The utilization of such versatile polymers allows for the creation of high-quality medical devices that meet stringent performance requirements while considering factors such as biocompatibility, mechanical properties, and degradation characteristics.…”
Section: Introductionmentioning
confidence: 99%